Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and... see more

GREY:ALEAF - Post Discussion

Aleafia Health Inc > Rapid decline in weed pricing seems
View:
Post by sthinei on Nov 14, 2021 9:25am

Rapid decline in weed pricing seems

To have ended due to a lot of production cuts from many operators. The largest portion of aleaf earnings going to come from adult market and they had pricing go from 4.90 to 6.60 in rec market. Wholesale fell large from last yearsemester q3 but up about 150% that we saw in q4. I am hoping and looking for pricing in wholesale to be closer to $1 in q4. Cronos has over $1 billion in cash and only posted like $11 million in Canadian pot sales and a $2 bln market cap, canopy has 2 bln in cash, aurora has $500 mln with additional cash available they ard all losing share in cdn rec market while tge likes of aleaf gaining share with value as well as high THC content product with low cost production. ALEAF looks like a bit of a steal at these levels. Canopy ceo comments below: "Market share softness across flower categories was driven by insufficient supply of flower with in-demand attributes, including higher THC, in the premium and mainstream categories as well heightened competition focused on single strain offerings in the value flower category."
Comment by KeyserShoze on Nov 14, 2021 10:13am
This post has been removed in accordance with Community Policy
Comment by LarryCurlyandMo on Nov 14, 2021 11:07am
Anyone interestwd in Aleafia flower knows what dire straights they're in. They will not be offered anything near fair market value.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities